Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $5.02 and traded as low as $4.91. Ono Pharmaceutical shares last traded at $4.94, with a volume of 39,150 shares.
Ono Pharmaceutical Trading Down 3.3%
The firm has a 50-day moving average of $5.02 and a two-hundred day moving average of $5.02.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of prescription medicines. The company focuses on areas including oncology, immunology, neurology and other serious diseases, with an emphasis on discovering therapies that address unmet medical needs.
Ono is best known for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb. Opdivo is used in multiple cancer indications, depending on regulatory approval in individual markets.
Further Reading
- Five stocks we like better than Ono Pharmaceutical
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
